Ocean Biomedical, Inc.
OCEAOTCCIK 1869974HealthcareFiscal year ends Dec 31
Reports and events: 111 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-08-0512:45 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001641172-25-022271 |
| 2025-07-2313:27 ET | 8-K | 3.01 Delisting notice | 0001641172-25-020730 |
| 2025-07-1613:25 ET | 8-K | 1.02 Termination of a material agreement | 0001641172-25-019924 |
| 2025-06-1313:25 ET | 8-K | 1.02 Termination of a material agreement | 0001641172-25-015129 |
| 2025-05-1513:22 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-011080 |
| 2025-04-2912:45 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001641172-25-006669 |
| 2025-04-2305:15 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-005788 |
| 2025-04-0806:11 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-003155 |
| 2025-04-0112:05 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-002074 |
| 2025-03-2612:10 ET | 8-K | 8.01 Other events | 0001641172-25-000747 |
| 2025-03-2012:55 ET | 8-K | 3.01 Delisting notice | 0001493152-25-011046 |
| 2025-03-1012:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-25-009707 |
| 2025-02-2612:20 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-008395 |
| 2025-02-2603:30 ET | DEF 14A | Proxy statementPeriod 2025-02-26 | 0001493152-25-008279 |
| 2025-02-2112:25 ET | 8-K | 5.03 Amendment to articles or bylaws | 0001493152-25-007933 |
| 2025-02-1212:20 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events | 0001493152-25-006180 |
| 2025-01-1512:51 ET | 8-K | 3.01 Delisting notice | 0001493152-25-002237 |
| 2025-01-1304:20 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-25-001880 |
| 2024-12-2302:51 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-051208 |
| 2024-12-2302:50 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-051207 |
| 2024-12-1711:30 ET | 8-K | 4.01 Change of auditor | 0001493152-24-050414 |
| 2024-12-1111:46 ET | 8-K | 3.01 Delisting notice | 0001493152-24-049647 |
| 2024-12-0911:30 ET | 8-K | 3.01 Delisting notice | 0001493152-24-049281 |
| 2024-12-0611:45 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-24-049099 |
| 2024-11-2512:29 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-047661 |
| 2024-11-2211:45 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-047421 |
| 2024-10-2912:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-042911 |
| 2024-10-2212:45 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-24-042071 |
| 2024-10-1713:06 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-041436 |
| 2024-08-2312:30 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-033729 |
| 2024-07-2313:26 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-028844 |
| 2024-05-3005:15 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-021880 |
| 2024-04-2413:20 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-015820 |
| 2024-04-1513:27 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-24-014679 |
| 2024-04-1513:26 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-06-30 | 0001493152-24-014678 |
| 2024-04-1513:25 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-03-31 | 0001493152-24-014676 |
| 2024-03-0812:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-009436 |
| 2024-03-0412:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-008720 |
| 2024-01-1912:05 ET | 8-K | 3.01 Delisting notice | 0001493152-24-003091 |
| 2024-01-1711:05 ET | 8-K | 3.01 Delisting notice | 0001493152-24-002701 |
| 2023-11-3013:12 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-043107 |
| 2023-11-1501:20 ET | 8-K | 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001493152-23-041387 |
| 2023-10-1213:10 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-037068 |
| 2023-10-0613:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-036565 |
| 2023-10-0316:20 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-035098 |
| 2023-09-0613:25 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-23-031878 |
| 2023-08-1412:05 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-028396 |
| 2023-08-0413:15 ET | DEF 14A | Proxy statementPeriod 2023-08-04 | 0001493152-23-026914 |
| 2023-07-0613:20 ET | S-1/A | Registration statement, amended | 0001493152-23-023856 |
| 2023-06-2209:58 ET | S-1 | Registration statement | 0001493152-23-022155 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.